Literature DB >> 11087572

6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.

M J Hour1, L J Huang, S C Kuo, Y Xia, K Bastow, Y Nakanishi, E Hamel, K H Lee.   

Abstract

As part of our continuing search for potential anticancer candidates among 2-phenyl-4-quinolones and 2-phenyl-4-quinazolinones, two series of 6,7,2',3',4',5'-substituted 2-phenyl-4-quinazolinones and 6,2',3',4',5'-substituted 2,3-dihydro-2-phenyl-4-quinazolinones were synthesized and evaluated for cytotoxicity and as inhibitors of tubulin polymerization. In general, a good correlation was found between the two activities. Five of the 6-substituted heterocyclic 2-phenyl-4-quinozolinones (37-51) showed significant cytotoxicity against a panel of human tumor cell lines with EC(50) values in the low micromolar to nanomolar concentration ranges. Compound 38 was the most potent of these compounds, as well as the most potent inhibitor of tubulin polymerization in this series. The activity of 38 was in the same range as those of the antimitotic natural products, colchicine, podophyllotoxin, and combretastatin A-4. Substituted 2-phenyl-4-quinazolinones and 2, 3-dihydro-2-phenyl-4-quinazolinones also displayed highly selective cytotoxicity against the ovarian cancer 1A9 and P-gp resistant KB-VIN cell lines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087572     DOI: 10.1021/jm000151c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

1.  Aggravated DNA damage as a basis for enhanced glioma cell killing by MJ-66 in combination with minocycline.

Authors:  Mann-Jen Hour; Wei-Ting Liu; I-Chen Lu; Sheng-Chu Kuo; Po-Wu Gean
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

2.  Design and synthesis of new 2-arylnaphthyridin-4-ones as potent antitumor agents targeting tumorigenic cell lines.

Authors:  Chin-Yu Liu; Yung-Yi Cheng; Ling-Chu Chang; Li-Jiau Huang; Li-Chen Chou; Chi-Hung Huang; Meng-Tung Tsai; Chih-Chang Liao; Mei-Hua Hsu; Hui-Yi Lin; Tian-Shung Wu; Yen-Fang Wen; Yu Zhao; Sheng-Chu Kuo; Kuo-Hsiung Lee
Journal:  Eur J Med Chem       Date:  2014-12-11       Impact factor: 6.514

3.  Styryl quinazolinones and its ethynyl derivatives induce myeloid differentiation.

Authors:  Sridhar Radhakrishnan; Riyaz Syed; Hisashi Takei; Ikei S Kobayashi; Eugene Nakamura; Farheen Sultana; Ahmed Kamal; Daniel G Tenen; Susumu S Kobayashi
Journal:  Bioorg Med Chem Lett       Date:  2019-06-20       Impact factor: 2.823

4.  Cytotoxic Activity and Three-Dimensional Quantitative Structure Activity Relationship of 2-Aryl-1,8-naphthyridin-4-ones.

Authors:  Yong Jin Kim; Eun Ae Kim; Mi Lyang Chung; Chaeuk Im
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

5.  A three component one-pot procedure for the synthesis of [1,2,4]triazolo/benzimidazolo-quinazolinone derivatives in the presence of H6P2W18O(62).18H2O as a green and reusable catalyst.

Authors:  Majid M Heravi; Leila Ranjbar; Fatemeh Derikvand; Behnoush Alimadadi; Hossien A Oskooie; Fatemeh F Bamoharram
Journal:  Mol Divers       Date:  2008-09-09       Impact factor: 2.943

6.  Design and synthesis of 2-(3-benzo[b]thienyl)-6,7-methylenedioxyquinolin-4-one analogues as potent antitumor agents that inhibit tubulin assembly.

Authors:  Yu-Hsun Chang; Mei-Hua Hsu; Sheng-Hung Wang; Li-Jiau Huang; Keduo Qian; Susan L Morris-Natschke; Ernest Hamel; Sheng-Chu Kuo; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

7.  A novel microtubule inhibitor, MT3-037, causes cancer cell apoptosis by inducing mitotic arrest and interfering with microtubule dynamics.

Authors:  Ling-Chu Chang; Yung-Luen Yu; Min-Tsang Hsieh; Sheng-Hung Wang; Ruey-Hwang Chou; Wei-Chien Huang; Hui-Yi Lin; Hsin-Yi Hung; Li-Jiau Huang; Sheng-Chu Kuo
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

8.  Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones.

Authors:  S Chandrappa; S B Benaka Prasad; K Vinaya; C S Ananda Kumar; N R Thimmegowda; K S Rangappa
Journal:  Invest New Drugs       Date:  2008-05-13       Impact factor: 3.850

9.  Asymmetric synthesis of 2,3-dihydro-2-arylquinazolin-4-ones: methodology and application to a potent fluorescent tubulin inhibitor with anticancer activity.

Authors:  Gary M Chinigo; Mikell Paige; Scott Grindrod; Ernest Hamel; Sivanesan Dakshanamurthy; Maksymilian Chruszcz; Wladek Minor; Milton L Brown
Journal:  J Med Chem       Date:  2008-07-09       Impact factor: 7.446

10.  MJ-66 induces malignant glioma cells G2/M phase arrest and mitotic catastrophe through regulation of cyclin B1/Cdk1 complex.

Authors:  Wei-Ting Liu; Ching Chen; I-Chen Lu; Sheng-Chu Kuo; Kuo-Hsiung Lee; Tai-Lin Chen; Ta-Shu Song; Yi-Liang Lu; Po-Wu Gean; Mann-Jen Hour
Journal:  Neuropharmacology       Date:  2014-08-05       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.